Sie sind auf Seite 1von 18

Sharing

Journal
Dadang Putrawansyah
(105070200131003)
Shof Khaqul Ily
(105070200131010)
!"sti #o$ita %ur P
(105070200131011)
Self-efcacy, self-care
behaviours and quality of
life of kidney transplant
Recipients
Li-Chueh Weng, et al. 2009
Background
Kidney transplantation (KT) is indicated in end-stage renal disease (ESRD)
Kidney transplantation (KT) is indicated in end-stage renal disease (ESRD)
Almost 50,000 kidney transplantations are performed annally in t!e "orld (#$% &00')
Almost 50,000 kidney transplantations are performed annally in t!e "orld (#$% &00')
T!e KT recipients contine to li(e "it! a c!ronic condition )ecase t!ey rn t!e risk of c!ronic re*ection,
infection or graft fnction failre (+irsc! &00')
T!e KT recipients contine to li(e "it! a c!ronic condition )ecase t!ey rn t!e risk of c!ronic re*ection,
infection or graft fnction failre (+irsc! &00')
Self-management !as )een recogni,ed on a "orld"ide )asis as an important aspect of sccessfl !ealt! care
(-oden!eimer et al. &00&, /innell &005).
Self-management !as )een recogni,ed on a "orld"ide )asis as an important aspect of sccessfl !ealt! care
(-oden!eimer et al. &00&, /innell &005).
+atients "it! greater self-efficacy !a(e )een s!o"n to practise more self-management )e!a(iors, leading to
)etter disease control, )etter p!ysical fnction and )etter 0%/ (1aines et al. &00&, Tsay 2 $alstead &00&)
+atients "it! greater self-efficacy !a(e )een s!o"n to practise more self-management )e!a(iors, leading to
)etter disease control, )etter p!ysical fnction and )etter 0%/ (1aines et al. &00&, Tsay 2 $alstead &00&)
Among KT recipients, only a fe" stdies !a(e e3plored t!e relations!ip )et"een self-efficacy and medication-
taking )e!a(ior, s!o"ing t!at KT recipients "it! !ig!er self-efficacy ad!ered )etter to medication-taking
)e!a(iors (De 1eest et al. 4555, 6!ris-tensen et al. &000, -aines et al. &00&)
Among KT recipients, only a fe" stdies !a(e e3plored t!e relations!ip )et"een self-efficacy and medication-
taking )e!a(ior, s!o"ing t!at KT recipients "it! !ig!er self-efficacy ad!ered )etter to medication-taking
)e!a(iors (De 1eest et al. 4555, 6!ris-tensen et al. &000, -aines et al. &00&)
Method
7
Time
A panel design "as sed to collect data from adlt KT
recipients at t"o points in time8 at t!e time of t!e first cross-sectional
data collection ()eginning in Septem)er &005) and 9 mont!s after
t!e first collection.
7
+atient 2 +lace
+atients "!o !ad recei(ed kidney transplants "ere recrited
from t!e otpatient clinic of a ',000-)ed tertiary pri(ate !ospital in
nort!ern Tai"an.
7 4:9 ptients (met criteria) '4 refsed to participate first data collection
of 455 patients (455;4:9, :','<) second collection (9 mont!s later) =
patients did>nt finis! t!e ?etionare @ 4 patient loss contact final sample
KT recipient 150 (450;455, 59,:<).
Valuation System
Taking into consideration access to participants and t!e need
for certain statistics, "e sed +ASS (po"er analysis and sample
si,e) soft"are to estimate t!e nm)er of participants needed.
!ata "ollection
+articipants "ere
identified )y
researc!ers
+atients met
inclsion t!e criteria
Agree to participate
Second collecting 8
on fe) 09 A Bo( 09
Cirst collecting 8
patient completed a
self-administered
?estion-naire
1ot DS E 45 as
t!anks for
participation
1ot "ritten consent
Retrn ?etionare
immadiately
Retrning time
#ntervention $nd Valuation
A. Health Related to QOL
$ealt!-related ?ality of life (0%/) "as measred )y t!e Fedical
%tcomes Scale, S!ort Corm (SC-'9), Tai"an (ersion, "!ic! "as
de(eloped to measre p!ysical and mental !ealt! as "ell as general
"ell-)eing (/et al. &00', #are 2 Kosinki &005).
"ont%
T!e data re(ealed t!at yonger patients ('0 years and yonger)
!ad statistically significant )etter +C and -+ t!an older patients (55
years and older).
B. Self-Management
o
Self-management "as measred )y t!e Kidney Transplanta-tion Self-
Fanagement Scale, "!ic! "as de(eloped )y t!e firstat!or )ased on
literatre re(ie" (#eng &00:).
o
T!is &G-item scale !as t!ree dimensions8 pro)lem-sol(ing, patientA
pro(ider partners!ip and self-care )e!a(ior.
C. Self-ffi!a!"
o
Self-efficacy for self-management "as measred )y t!e Kidney
Transplantation Self-6are Self-Efficacy Scale.
o
T!is 4'-item scale assesses patients> confidence in t!eir a)ility to follo"
prescri)ed diet, e3ercise and medication regimen to monitor early signs of
re*ection and infection to monitor )lood pressre and ot!er p!ysical
parameters and to monitor emotional distress.
"ont
D. #$"!ho-%h"$i!al $t&e$$
Depressi(e symptoms "ere measred )y t!e &4-item 6!inese
(ersion of t!e -eck Depression Hn(entory.
. 'emog&a%hi! data and &enal g&aft fun!tion
Data "ere collected on age, se3, crrent immnosppressi(e
drg regimen, !man lecocyte antigen ($/A) typing and sorce of
donor kidney.
6ockcroft-1alt formla (Cranklin &00&)8
c1CR I J(4=0 - age);serm creatinine le(elK 3 J)ody "eig!t;G&K
!ata $nalysis
T!e measrement of self-efficacy
"as )ased on t!e data collected at t!e first
point in time, "!ile t!e measrement of self-
management and 0%/ "as )ased on data
collected at t!e second point. %t!er data,
"!ic! ser(ed as control (aria)les, "ere
sed for t!e first time data in t!e regression
model.
Reslt
Effect of self-efficacy and self-management on p!ysical and mental
!ealt! of 0%/
Self-efficacy "as
fond statistically
significantly ( + L0,04),
positi(ely, and directly to
inflence t!e self-
management dimensions
of pro)lem-sol(ing,
patientApro(ider
partners!ip and self-care
)e!a(ior ( ) I0,54, 0, ==
and 0,55 respecti(ely)
Ta)le.' Bo statistically
significant direct effect
"as fond for self-
efficacy on p!ysical and
mental !ealt!.
!iscussion
"onclusion
7 Self-efficacy can impro(e self-management and "ill )enefit 0%/
indirectly for patients "it! KT.
7 T!eir self-efficacy can )e promoted )y for strategies8 mastery,
modelling, persasion and learning.
7 Self-care )e!a(ior "as fond to )e positi(ely and directly
associated "it! 0%/.
7 T!e goal is to familiari,e patients "it! t!ese )e!a(iors, encorage
t!em to participate in t!eir care, gi(e t!em confidence, and !elp
t!em to reali,e t!eir responsi)ility in post-KT care.
ADMABTA1ES
7
DHSADMABTA1ES
A++/H6ATH%BS HB HBD%BESHA
Thank You,.

Das könnte Ihnen auch gefallen